1. Home
  2. NGVT vs IDYA Comparison

NGVT vs IDYA Comparison

Compare NGVT & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGVT
  • IDYA
  • Stock Information
  • Founded
  • NGVT 1964
  • IDYA 2015
  • Country
  • NGVT United States
  • IDYA United States
  • Employees
  • NGVT N/A
  • IDYA N/A
  • Industry
  • NGVT Major Chemicals
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NGVT Industrials
  • IDYA Health Care
  • Exchange
  • NGVT Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • NGVT 1.7B
  • IDYA 2.0B
  • IPO Year
  • NGVT N/A
  • IDYA 2019
  • Fundamental
  • Price
  • NGVT $44.90
  • IDYA $25.38
  • Analyst Decision
  • NGVT Buy
  • IDYA Strong Buy
  • Analyst Count
  • NGVT 5
  • IDYA 13
  • Target Price
  • NGVT $51.00
  • IDYA $53.67
  • AVG Volume (30 Days)
  • NGVT 207.9K
  • IDYA 825.9K
  • Earning Date
  • NGVT 02-18-2025
  • IDYA 02-18-2025
  • Dividend Yield
  • NGVT N/A
  • IDYA N/A
  • EPS Growth
  • NGVT N/A
  • IDYA N/A
  • EPS
  • NGVT N/A
  • IDYA N/A
  • Revenue
  • NGVT $1,479,300,000.00
  • IDYA $3,922,000.00
  • Revenue This Year
  • NGVT N/A
  • IDYA N/A
  • Revenue Next Year
  • NGVT $2.43
  • IDYA $273.42
  • P/E Ratio
  • NGVT N/A
  • IDYA N/A
  • Revenue Growth
  • NGVT N/A
  • IDYA N/A
  • 52 Week Low
  • NGVT $30.90
  • IDYA $22.10
  • 52 Week High
  • NGVT $56.30
  • IDYA $47.74
  • Technical
  • Relative Strength Index (RSI)
  • NGVT 52.75
  • IDYA 48.30
  • Support Level
  • NGVT $42.95
  • IDYA $23.29
  • Resistance Level
  • NGVT $46.52
  • IDYA $24.97
  • Average True Range (ATR)
  • NGVT 1.61
  • IDYA 1.05
  • MACD
  • NGVT -0.03
  • IDYA 0.21
  • Stochastic Oscillator
  • NGVT 52.49
  • IDYA 70.03

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

Share on Social Networks: